Iraq News - Local News - Baghdadpost

EU grants clearance to remdesivir to treat coronavirus patients


The European Commission has granted conditional clearance to antiviral remdesivir to treat coronavirus positive patients, Reuters reported.


The EU executive said the drug, produced by Gilead Sciences Inc, was the first medicine authorized in the European Union for treating COVID-19 following a "rolling review" begun by the European Medicines Agency at the end of April.